113 related articles for article (PubMed ID: 35727197)
21. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
22. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling.
Jin X; Liu X; Zhang Z; Xu L
Biochem Biophys Res Commun; 2020 Dec; 533(3):354-361. PubMed ID: 32962856
[TBL] [Abstract][Full Text] [Related]
23. DYNC1H1 regulates NSCLC cell growth and metastasis by IFN-γ-JAK-STAT signaling and is associated with an aberrant immune response.
Pan H; Chai W; Liu X; Yu T; Sun L; Yan M
Exp Cell Res; 2021 Dec; 409(1):112897. PubMed ID: 34717919
[TBL] [Abstract][Full Text] [Related]
24. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
Zheng J; Xu T; Chen F; Zhang Y
Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
[TBL] [Abstract][Full Text] [Related]
25. miR‑150 promotes the proliferation and migration of non‑small cell lung cancer cells by regulating the SIRT2/JMJD2A signaling pathway.
Jiang K; Shen M; Chen Y; Xu W
Oncol Rep; 2018 Aug; 40(2):943-951. PubMed ID: 29901178
[TBL] [Abstract][Full Text] [Related]
26. SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer.
Li J; Zhao L; Pan Y; Ma X; Liu L; Wang W; You W
Int J Oncol; 2020 Sep; 57(3):756-766. PubMed ID: 32705243
[TBL] [Abstract][Full Text] [Related]
27. GRWD1 promotes cell proliferation and migration in non-small cell lung cancer by activating the Notch pathway.
Wang Q; Ren H; Xu Y; Jiang J; Wudu M; Liu Z; Su H; Jiang X; Zhang Y; Zhang B; Qiu X
Exp Cell Res; 2020 Feb; 387(2):111806. PubMed ID: 31891681
[TBL] [Abstract][Full Text] [Related]
28. MiR-572 promotes the development of non-small cell lung cancer by targeting KLF2.
Sun B; Zhao J; Shao ZY
Eur Rev Med Pharmacol Sci; 2022 May; 26(9):3083-3090. PubMed ID: 35587058
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of
Zhou Y; Yuan Y; Zhang Q; Shen Y; Chen W; Yan L
Ann Clin Lab Sci; 2022 Sep; 52(5):753-762. PubMed ID: 36261188
[TBL] [Abstract][Full Text] [Related]
30. NUSAP1 knockdown inhibits cell growth and metastasis of non-small-cell lung cancer through regulating BTG2/PI3K/Akt signaling.
Xu Z; Wang Y; Xiong J; Cui F; Wang L; Peng H
J Cell Physiol; 2020 Apr; 235(4):3886-3893. PubMed ID: 31603257
[TBL] [Abstract][Full Text] [Related]
31. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
Wang A; Wang J
DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
[TBL] [Abstract][Full Text] [Related]
32. Upregulation of microRNA-1303 is a potential prognostic marker of non-small cell lung cancer.
Chen J; Jiang T; Yu B; Li T; Zhao P; Yuan L; Qi J
Cancer Biomark; 2020; 28(4):439-446. PubMed ID: 32508320
[TBL] [Abstract][Full Text] [Related]
33. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
Yang J; Du YM; Li B
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
[TBL] [Abstract][Full Text] [Related]
34. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
[TBL] [Abstract][Full Text] [Related]
35. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
36. CIAPIN1 Targeted NHE1 and ERK1/2 to Suppress NSCLC Cells' Metastasis and Predicted Good Prognosis in NSCLC Patients Receiving Pulmonectomy.
Wang J; Zhou Y; Ma L; Cao S; Gao W; Xiong Q; Wang K; Yang L
Oxid Med Cell Longev; 2019; 2019():1970818. PubMed ID: 31093311
[TBL] [Abstract][Full Text] [Related]
37. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
[TBL] [Abstract][Full Text] [Related]
38. ARMC8α promotes proliferation and invasion of non-small cell lung cancer cells by activating the canonical Wnt signaling pathway.
Xie C; Jiang G; Fan C; Zhang X; Zhang Y; Miao Y; Lin X; Wu J; Wang L; Liu Y; Yu J; Yang L; Zhang D; Xu K; Wang E
Tumour Biol; 2014 Sep; 35(9):8903-11. PubMed ID: 24894675
[TBL] [Abstract][Full Text] [Related]
39. MiR-940 inhibits the progression of NSCLC by targeting FAM83F.
Gu GM; Zhan YY; Abuduwaili K; Wang XL; Li XQ; Zhu HG; Liu CL
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5964-5971. PubMed ID: 30280778
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of miR-4286 is an unfavorable prognostic marker in individuals with non-small cell lung cancer.
An X; Ge J; Guo H; Mi H; Zhou J; Liu Y; Weiyue ; Wu Z
J Cell Biochem; 2019 Oct; 120(10):17573-17583. PubMed ID: 31111550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
